Figure S2. ChIP and western analyses. Related to Figure 2C-D and Figure 4F-G. (A)
Degree of genome-wide colocalization between epigenetic modifications, measured as odds ratio (Xiao et al, 2012) . Co-localizations that are larger, equal, and smaller than that from random permutation were plotted in red, white, and blue, respectively. (B) Size distributions of ChIP-seq peaks, called by MACS14 on E14 ES cell ChIP-seq data. (C) Cumulative overlap of the top ranked SMARCAD1 ChIP-seq peaks with H3K9me3 marked regions (red curve), as compared to that of SETDB1 and H3K9me3 (positive control, green) , and NANOG and H3K9me3 (negative control, purple). (D) Venn diagram of SMARCAD1, SETDB1, and H3K9me3 peaks. (E) Distribution of distances between the centers of neighboring nucleosomes (y axis) in SMARCAD1 peaks (first column), H3R26Cit peaks occupied by SMARCAD1 (H3Cit-SMARCAD1), and the entire genome (third column). (F) Western blot showing the specificity of the SMARCAD1 antibody (Abcam, ab67548) . Fluorescence is acquired from secondary antibodies, applied to SMARCAD1 primary antibody (green) and ladder (red). (G) Western blots of H3K9me2 and H3K9me3 in Luciferase KD (Control) and Smarcad1 KD (KD) cells. These are biological replicates to the data shown in Figure 4F -G. . (E) Association between SMARCAD1 peaks and major classes of genomic repeats (x axis). Odds ratio (y axis, in log scale) was used to quantify the association, comparing the fraction of SMARCAD1 peaks that contain a class of repeats to the genome. A positive log odds ratio suggests enrichment. (F) Association of Smarcad1 KD induced H3K9me3 peaks with genomic repeats and other genomic features (x axis). A positive log odds ratio (y axis) suggests an enrichment of H3K9me3 changes in this class of repeats. Table S1 . Summary of teratomas. Related to Figure 3 . The teratomas originating from control knockdown cells (Control column) and from SMARCAD1 knockdown (KD column). L, R: the side of the body. Y: tumor found at this site. N: no tumor found. (Tesar et al., 2007) were from different manufacturers, which were not expected to reproduce the detected differentially expressed genes (Fortunel et al., 2003) . However, the microarray detected differentially expressed genes between Smarcad1 KD and ES cells were correlated with that between primed and naïve pluripotent cells (Tesar et al., 2007 ) (p-value = 5×10 -8 , Chisquare test). We compared our RNA-seq data with published RNA-seq data in EpiSC and ES cells (GSE57403) (Factor et al., 2014) . Based on all the genes (13,599) with detectable expression (FPKM ≥ 0.1) in least one RNA-seq dataset, the genomewide expression changes between Smarcad1 KD and ES cells exhibited a weak correlation with the genomewide changes between EpiSC and ES cells (p-value < 10 -15 , T test) ( Figure S3F ). Next, we identified and compared the differentially expressed genes (1,313) between Smarcad1 KD and control ES cells (log fold change > 1 or <-1) with the differentially expressed genes (3,998) between EpiSC and ES cells (log fold change > 1 or <-1). The up-or down-regulated genes in Smarcad1 KD were associated with that in EpiSC (odds ratio = 10.8, p-value < 10 -20 , Chi-squared test, Figure S3G ).
SUPPLEMENTARY TABLES
Mouse Injection Control KD 1 L (Control), R Y (L) Y (R) 1 L (Control), R Y (L) Y (R) 2 L, R (Control) Y (R) Y (L) 2 L, R (Control) Y (R) N 3 L (Control), R Y (L) Y (R) 3 L (Control), R Y (L) Y (R) 4 L, R (Control) Y (R) Y (L) 4 L, R (Control) N Y (L)
Potential association of retrotransposons and satellite repeats with Smarcad1 KD mediated H3K9me3 changes
It remains unresolved whether any genomic features are associated with SMARCAD1 accessed genomic loci. Our de novo motif search did not identify significant sequence motifs in SMARCAD1 peaks. However, more LTR retrotransposons and satellites appeared in SMARCAD1 peaks than expected from the genome average ( Figure S6F ). Considering that our HT-SELEX experiment failed to identify SMARCAD1 binding to specific DNA sequences in vitro, this enrichment may reflect binding preferences of co-factors rather than that of SMARCAD1 itself.
Next, we examined genomic features associated with Smarcad1 KD induced H3K9me3 peaks. We considered 7 types of DNA repeats and other genomic features including CpG islands, intragenic regions, promoters, exons, introns, and 3' untranslated regions. Smarcad1 KD induced H3K9me3 peaks were enriched in satellites and LTR retrotransposons, as compared to the genome background (Fisher's Exact Test p-value < 10 -8 ) ( Figure S6G ). Interestingly, although this analysis was independent of SMARCAD1 ChIP-seq data, it prioritized the same genomic features as that enriched in SMARCAD1 peaks.
SUPPLEMENTARY METHODS

Immunosurgery of mouse blastocysts
Mouse ICMs were surgically isolated from 3.5 day blastocysts by cutting off the zona pellucida and tearing off the trophoblastic layer from the nudity blastocyst as previously described (Sviridova-Chailakhyan et al., 2008) .
RNA-seq experiment
RNA extraction and amplification from preimplantation embryos and ICM were carried out as described before (Xie et al., 2010) . The amplified RNAs were subjected to sequencing using Illumina's small sample RNA-seq protocol.
Cell culture
Mouse E14, Ogr1 (Chowdhury et al., 2010 ) ES cells and SMARCAD1 KD ES cells were cultured under feeder-free condition with LIF supplementation as previously described (Li et al., 2011) . EpiSCs were a gift from Azim Surani (Bao et al., 2009 ). Switch to EpiSC culture medium was described in Methods of the main text. Pig naïve ES cells and primed iPS cells were maintained as previously described (Ezashi et al., 2009; Telugu et al., 2011) . The vendor's website has western blots showing the specificity of these antibodies. The H3R26Cit antibody was used in Zhang et al., PNAS 2012 . The other protein and histone antibodies were used a number of previous publications including Xiao et al., Cell 2012 (Xiao et al., 2012 .
Western blot
RNA knockdown
Two shRNAs targeting different parts of the mouse Smarcad1 mRNA were constructed by cloning oligos into pSUPER.puro (BglII and HindIII sites, Oligoengine) (Hong et al., 2009 ). The shRNA sequences were: GAAGAGCGTAAGCAAATTA, GTATGAGGATTACAATGTA. Both pSUPER.puro and a pSUPER.puro loaded with a shRNA targeting Firefly Luciferase mRNA (pSuper-Luci) were used as controls. Cells were transfected with shRNA constructs by Lipofectamine 2000 (Invitrogen) followed by Puromycin (Sigma) selection. The ES cells were digested with dispase and subcultured 5 days after shRNA transfection. Cell images and western blots were generated 10 days after transfection. All procedures were repeated with identical procedures except one step, in which trypsin-EDTA was used for digestion on the 5 th day.
Alkaline Phosphatase (AP) staining
An AP detection kit (Millipore) was used for AP staining. Images were taken from an AMG EVOS XL microscope.
Xist expression
Female mouse ES cells EL16.6 (Zhao et al., 2008) were transfected with shRNAs against Smarcad1 and Luciferase and puromycin selected. Xist qPCR were carried out as previously described, using Xist specific probes that cannot amplify Tsix (Zhao et al., 2008) .
Chimera analysis
Ogr1 ES cells were used for chimera analysis, as previously described (Li et al., 2011) . Ogr1 ES cells "contain an Oct4-GFP transgenic reporter under the control of the entire 18Kb Oct4 regulatory sequences" (Yeom et al., 1996) . We injected Smarcad1 KD Ogr1 and Ogr1 cells into 3.5 day embryos (C57/BL6) and checked for chimera formation in approximately the next 28 -32 hours.
Teratoma generation and histological analysis
Cells were collected by triple digestion, re-suspended in PBS (2x10 6 cells / 25uL of PBS), mixed with collagen (0.3mg/mL), and injected into 4 female mice. Each mouse received 4 subcutaneous injections with 2 injections per flank. Teratomas were collected 28 days after injections and fixed with 4% paraformaldehyde. Two of the four mice developed an equal number of teratomas from Smarcad1 KD cells and from control cells (Mice 1 and 3 in Table S1 ). The other two mice developed unbalanced number of teratomas: one had two tumors from Smarcad1 KD cells and one tumor from control cells, and the other had a reversed scenario (Mice 2 and 4 in Table S1 ). Slices of the fixed teratomas were stained with Hematoxylin and Eosin, and imaged with a NanoZoomer Digital Pathology System (Hamamatsu).
Quantification of metabolic features
Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were quantified as previously described (Zhou et al., 2012) . Briefly, approximately 150,000 control (Luciferase KD) and Smarcad1 KD cells in confluence are subjected to measurement by a Seahorse XF Analyzer (Agilent), at three time points (1, 8, and 15 minutes). Culture medium was changed into a base medium (unbuffered DMEM (Sigma D5030) supplemented with 2 mM Glutamine) 1 hour before the assay. Three biological replicates were measured. After the assay, cells were lysed and protein weight was measured by NanoDrop TM 1000 Spectrophotometer. The protein weights were used to normalize OCR and ECAR.
RT-PCR
Total RNA was extracted, and first-strand cDNA was synthesized with an M-MLV Synthesis System (New England Biolabs) and subsequently analyzed with an Applied Biosystems 7900HT Fast Real-Time PCR System. Primer sequences are listed in Table S2 . β-actin was used as the internal control to normalize cycle numbers.
Embryoid body (EB) formation
Clusters of 200 cells were suspended in 30 μL of stem cell media without LIF. These droplets were hung on a petri dish cap for 3 days, and then collected and maintained with mild shaking in a 37 C incubator for 14 days. EB images were taken on the 14th day of incubation.
Gene Expression Microarray
Total RNA was isolated with Trizol (Invitrogen), labeled, and hybridized onto Agilent-014868 Whole Mouse Genome Microarray 4x44K G4122F.
ChIP-Seq and data analysis
ChIP-Seq was carried out as previously described (Xiao et al., 2012) with E14 ES cells, Smarcad1 KD E14 ES cells, and CI-Amidine treated E14 cells. The antibodies were SMARCAD1 (Abcam, ab67548), H3R26Cit
